Lamivudine improves the prognosis of patients with hepatitis B after liver transplantation
Authors:
- M SterneckMSM Sterneck
- B ZöllnerBZB Zöllner
- X RogiersXRX Rogiers
- 1 November 2000
- journal article
- research article
- Published by Elsevier in Transplantation Proceedings
- Vol. 32 (7) , 2128-2130
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- A One-Year Trial of Lamivudine for Chronic Hepatitis BNew England Journal of Medicine, 1998
- Lamivudine resistance inimmunocompetent chronic hepatitis BJournal of Hepatology, 1997
- Synergistic inhibition of hepadnaviral replication by lamivudine in combination with penciclovir in vitroHepatology, 1997
- Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantationThe Lancet, 1997
- Famciclovir treatment of hepatitis B virus recurrence after liver transplantation: A pilot studyLiver Transplantation and Surgery, 1996
- Liver Transplantation in European Patients with the Hepatitis B Surface AntigenNew England Journal of Medicine, 1993